W Louis Cleveland Robert L DeLaPaz Rashid A Fawwaz Roger S Challop
10.1155/2009/768398
Neural Plast
2009;2009:768398.
CC BY
https://pubmed.ncbi.nlm.nih.gov/20182547/
Body Dysmorphic Disorders / drug therapy Glycine / therapeutic use Obsessive-Compulsive Disorder / drug therapy Psychotropic Drugs / therapeutic use
Body Dysmorphic Disorders / drug therapy Glycine / therapeutic use Obsessive-Compulsive Disorder / drug therapy Psychotropic Drugs / therapeutic use Case Reports Research Support, Non-U.S. Gov't Body Dysmorphic Disorders / diagnosis Body Dysmorphic Disorders / metabolism Glycine / administration & dosage Glycine Agents / administration & dosage Glycine Agents / therapeutic use Humans Male Models, Neurological Obsessive-Compulsive Disorder / diagnosis Obsessive-Compulsive Disorder / metabolism Psychotropic Drugs / administration & dosage Receptors, N-Methyl-D-Aspartate / metabolism Signal Transduction Time Factors Treatment Outcome Young Adult Glycine Agents Psychotropic Drugs Receptors, N-Methyl-D-Aspartate Glycine
PMC2825652
20182547
High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period
2009